Inactive Instrument

POZEN Inc. Stock

Stocks

US73941U1025

Pharmaceuticals

End-of-day quote Nasdaq
- ^USD	-

Press Releases: POZEN Inc.

03/02/16	POZEN : Announces Stockholder Approval of its Transaction with Tribute Pharmaceuticals Canada Inc.	PR
08/12/15	POZEN : And Tribute Announce Plan To Proceed With Merger To Form Aralez Pharmaceuticals	PR
08/12/15	POZEN : and Tribute Announce Plan to Proceed With Merger to Form Aralez Pharmaceuticals	MW
09/11/15	POZEN : Reports Third Quarter 2015 Results	BU
07/11/15	POZEN : and Tribute Announce Effectiveness of Registration Statement on Form S-4	BU

More press releases

News in other languages: POZEN Inc.

02/12/14	Sanofi : Pozen met fin à son accord de commercialisation sur 2 médicaments en développement
05/09/13	SANOFI : obtient les droits de commercialisation de médicaments développés par Pozen

Managers and Directors: POZEN Inc.

Manager	Title	Age	Since
John E. Barnhardt ADM	Chief Administrative Officer	76	-

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	ELI LILLY AND COMPANY	+0.70%	+1.78%	+50.36%	+100.07%	1,014B
	JOHNSON & JOHNSON	+0.54%	+0.69%	+51.34%	+65.06%	644B
	ABBVIE INC.	-0.01%	+2.66%	+18.56%	+70.06%	464B
	ROCHE HOLDING AG	-0.34%	+4.11%	+38.13%	+39.45%	354B
	NOVARTIS AG	+1.65%	+3.28%	+19.92%	+25.86%	265B
	ASTRAZENECA PLC	+1.93%	+4.81%	+8.14%	+14.88%	253B
	AMGEN INC.	+0.80%	-0.97%	+37.88%	+43.94%	203B
	NOVO NORDISK A/S	+2.14%	-2.39%	-24.37%	-57.03%	186B
	GILEAD SCIENCES, INC.	+0.20%	+2.16%	+31.79%	+95.64%	183B
	Average	+0.88%	+0.96%	+25.75%	+44.21%	396.31B
	Weighted average by Cap.	+0.72%	+1.41%	+34.37%	+60.65%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!